Fate Therapeutics (FATE) Operating Margin (2016 - 2025)
Historic Operating Margin for Fate Therapeutics (FATE) over the last 14 years, with Q3 2025 value amounting to 1995.12%.
- Fate Therapeutics' Operating Margin fell 2912500.0% to 1995.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 2448.24%, marking a year-over-year decrease of 9861800.0%. This contributed to the annual value of 1542.63% for FY2024, which is 12427700.0% down from last year.
- Per Fate Therapeutics' latest filing, its Operating Margin stood at 1995.12% for Q3 2025, which was down 2912500.0% from 1938.54% recorded in Q2 2025.
- In the past 5 years, Fate Therapeutics' Operating Margin ranged from a high of 48.48% in Q1 2023 and a low of 6705.79% during Q2 2023
- Over the past 5 years, Fate Therapeutics' median Operating Margin value was 665.73% (recorded in 2024), while the average stood at 1589.41%.
- Per our database at Business Quant, Fate Therapeutics' Operating Margin plummeted by -62577400bps in 2023 and then skyrocketed by 60400600bps in 2024.
- Over the past 5 years, Fate Therapeutics' Operating Margin (Quarter) stood at 406.48% in 2021, then surged by 64bps to 145.23% in 2022, then plummeted by -1875bps to 2868.44% in 2023, then fell by -16bps to 3319.78% in 2024, then skyrocketed by 40bps to 1995.12% in 2025.
- Its Operating Margin stands at 1995.12% for Q3 2025, versus 1938.54% for Q2 2025 and 2534.07% for Q1 2025.